Eikon Therapeutics Email Format

Biotechnology Research
201-500 employees
Millbrae, CA, USA

Eikon Therapeutics is a late-stage clinical biopharmaceutical company developing novel therapies for oncology and neurological diseases using single-molecule imaging and machine learning.

Find contacts at Eikon Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

lastfirstinitial@eikontx.com

Company Overview

Industry
Biotechnology Research
Founded
2019
Headquarters
Millbrae, CA, USA
Revenue
$25M-$50M
FUNDING Stage
Private
Key Executives
Roger M. Perlmutter (Chief Executive Officer and Board Chair), Alfred Lloyd Bowie Jr. (Chief Financial Officer), Michael Klobuchar (Chief Operating Officer)

Tech Stack

Okta

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Eikon Therapeutics?

Eikon Therapeutics uses the firstinitiallast format on eikontx.com, so Jane Smith would be jsmith@eikontx.com.

What therapeutic areas does Eikon Therapeutics focus on?

Eikon Therapeutics has active programs in oncology, immunology, and neuroscience. Its most advanced clinical asset, EIK1001, is a TLR7/8 co-agonist in Phase III trials for advanced melanoma, while EIK1003 and EIK1004 target PARP1 across multiple cancer types.

How does Eikon Therapeutics use its single molecule tracking platform in drug discovery?

Eikon Therapeutics uses its proprietary single molecule tracking (SMT) platform to visualize protein motion events in living cells, capturing up to hundreds of thousands of protein trajectories. This approach helps identify and validate therapeutic targets across its oncology and neuroscience pipeline.

Who leads Eikon Therapeutics as CEO?

Roger M. Perlmutter serves as CEO and Board Chair of Eikon Therapeutics. He previously led R&D at both Merck and Amgen, where he oversaw development of multiple approved drugs over more than 35 years in the industry.

How can I find and verify contact details for someone at Eikon Therapeutics?

Eikon Therapeutics uses the firstinitiallast format on eikontx.com, so if you know someone's name you can construct their address directly. A tool like Clay can help you verify the address and enrich your outreach list with additional Eikon Therapeutics contacts at the same time.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles